Drug Prices Across Countries - Pharma

Relevant Publications

An assessment of the implications of distribution remuneration and taxation policies on the final prices of prescription medicines: evidence from 35 countries.

Issue Release: 2024

A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key Stakeholders.

Issue Release: 2024

Modelling the opportunity for cost-savings or patient access with biosimilar adalimumab and tocilizumab: a European perspective.

Issue Release: 2024

Breast cancer drugs: FDA approval, development time, efficacy, clinical benefits, innovation, trials, endpoints, quality of life, value, and price.

Issue Release: 2024

Projected health and economic effects of a pan-tuberculosis treatment regimen: a modelling study.

Issue Release: 2024

Accessibility crisis of essential medicines at Sudanese primary healthcare facilities: a cross-sectional drugs\' dispensaries assessment and patients\' perspectives.

Issue Release: 2023

Antifungal Use and Resistance in a Lower-Middle-Income Country: The Case of Lebanon.

Issue Release: 2023

Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment.

Issue Release: 2023

Correlation of Anticancer Drug Prices with Outcomes of Overall Survival and Progression-Free Survival in Clinical Trials in Japan.

Issue Release: 2023

Cost-Effectiveness Analyses in AML: What Have We Learned, How Should This Impact Patient Care, and What Needs to Be Done in the Future?

Issue Release: 2023

The cancer premium - explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectional study.

Issue Release: 2023

Estimates of Medicaid and Non-Medicaid Net Prices of Top-Selling Brand-name Drugs Incorporating Best Price Rebates, 2015 to 2019.

Issue Release: 2023

Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.

Issue Release: 2023

Pharmaco-disparities in heart failure: a survey of the affordability of guideline recommended therapy in 10 countries.

Issue Release: 2023

Added Therapeutic Benefit of Top-Selling Brand-name Drugs in Medicare.

Issue Release: 2023

Generic Price Regulation and Drug Expenditures: Evidence from Canada.

Issue Release: 2023

Variations in global prices of chemotherapy for childhood cancer: a descriptive analysis.

Issue Release: 2023

[Variability in Drug Procurement within Group 1B of the Pharmaceutical Specialized Scheme in Brazil].

Issue Release: 2023

The impact of drug shortages on drug prices: evidence from China.

Issue Release: 2023

A cost analysis and availability scenario of drugs and oral care products prescribed for common oral conditions with reference to the current Indian market prices, Jan Aushadhi, and the state medical commissions.

Issue Release: 2022

What are the Challenges Faced by Generic Manufacturers?

How Can ADEs be Prevented?

What is Medication Management?

How Can Technology Aid in Management?

What Are Clinical Trials?

What is Generic Competition?

What Are the Challenges in Managing Chronic Conditions?

What is Cellular Stress?

What is the Future of Patient Education in Pharma?

What are Chronic Conditions?

Partnered Content Networks

Relevant Topics